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Widrick, Jeffrey J., Jill J. Bangart, Miloslav
Karhanek, and Robert H. Fitts. Soleus fiber force and
maximal shortening velocity non-weight bearing with inter-
mittent activity. J. Appl. Physiol. 80(3): 981-987, 1996.--This
study examined the effectiveness of intermittent weight
bearing (IWB) as a countermeasure to non-weight-bearing
(NWB)-induced alterations in soleus type I fiber force (in
mN), tension (Po; force per fiber cross-sectional area in
kN/m-2), and maximal unloaded shortening velocity (Vo, in
fiber lengths/s). Adult rats were assigned to one of the
following groups: normal weight bearing (WB), 14 days of
hindlimb NWB (NWB group), and 14 days of hindlimb NWB
with IWB treatments (IWB group). The IWB treatment
consisted of four 10-min periods of standing WB each day.
Single, chemically permeabilized soleus fiber segments were
mounted between a force transducer and position motor and
were studied at maximal Ca 2+ activation, after which type I
fiber myosin heavy-chain composition was confirmed by so-
dium dodecyl sufate-polyacrylamide gel electrophoresis. NWB
resulted in a loss in relative soleus mass (-45%), with type I
fibers displaying reductions in diameter (-28%) and peak
isometric force (-55%) and an increase in Vo (+33%). In
addition, NWB induced a 16% reduction in type I fiber Po, a
41% reduction in type I fiber peak elastic modulus [Eo, defined
as (Aforce/Alength) x (fiber length/fiber cross-sectional area]
and a significant increase in the Po/Eo ratio. In contrast to
NWB, IWB reduced the loss of relative soleus mass (by 22%)
and attenuated alterations in type I fiber diameter (by 36%),
peak force (by 29%), and Vo (by 48%) but had no significant
effect on Po, Eo, or Po/Eo. These results indicate that a modest
restoration of WB activity during 14 days of NWB is sufficient
to attenuate type I fiber atrophy and to partially restore type I
peak isometric force and ]7o to WB levels. However, the
NWB-induced reductions in Po and Eo, which we hypothesize
to be due to a decline in the number and stiffness of cross
bridges, respectively, are considerably less responsive to this
countermeasure treatment.
muscle atrophy; hindlimb suspension; hindlimb unloading;
countermeasures
THE ABSENCE OF NORMAL weight-bearing (WB) activity
during spaceflight produces rapid alterations in anti-
gravity muscle mass and function. After exposure to as
little as 4-7 days of zero gravity, the rodent soleus
exhibits a 20-37% reduction in mass, a parallel decline
in force production, and a significant increase in fatiga-
bility (1, 17, 20). Similarly, human crew members
returning from extended spaceflight display atrophy,
weakness, and increased fatigability of the antigravity
muscles of the lower limbs (2). These observations
underscore the necessity of designing and implement-
ing in-flight countermeasures to prevent detrimental
changes in muscle mass and function during long-
duration space missions.
Rodent hindlimb suspension is often used as a ground-
based model with which to study non-weight-bearing
(NWB) muscle atrophy because it produces changes in
muscle mass and function that are quantitatively simi-
lar to those observed after spaceflight (1, 5, 7, 16, 17, 20,
29, 31). This model has recently been used to test the
effectiveness of various interventions designed to pre-
vent or attenuate antigravity muscle atrophy during
NWB. Perhaps the simplest and most straightforward
of these countermeasures has been to provide intermit-
tent periods of weight support over the course of NWB.
Four brief sessions (10-15 min/session) of weight sup-
port each day during 7 days of NWB preserved soleus
wet weight (3, 26), whereas a single daily session of
either 2 or 4 h of weight support reduced soleus atrophy
by -50% over a 28-day period of NWB (31). Further-
more, intermittent weight support prevented the de-
cline in soleus peak isometric force observed after
7 days of NWB (26). These results indicate that some
form of intermittent weight bearing (IWB) may be an
effective countermeasure to NWB-induced muscle atro-
phy. During spaceflight, when normal WB is impos-
sible, centrifugation may prove to be an alternative
method of"reloading" antigravity muscles (3, 4).
A major aim of this laboratory is to understand how
NWB alters cross-bridge mechanisms of muscle contrac-
tion. Studies performed on single skinned type I soleus
fibers indicate that the reduction in force after NWB is
not only due to simple fiber atrophy but also to a
reduction in fiber tension (Po), or the force produced per
unit cross-sectional area (CSA) of the fiber (8, 21, 22).
Recent measurements of peak elastic modulus (Eo),
which is thought to reflect the relative number of
actomyosin cross-bridge attachments per CSA (15),
indicate that this reduction in Po is due to fewer cross
bridges per CSA after NWB (23). In addition to changes
in force production, the majority of the fibers that
express type I myosin heavy chain (MHC) after NWB
also display an elevated maximal unloaded shortening
velocity (Vo) (8, 22). Thus, in this population of fibers,
there is an increase in the maximal cross-bridge cycling
rate that appears to be dissociated from fiber MHC
expression.
Although intermittent weight support has been shown
to reduce the muscle atrophy induced by NWB, the
extent to which this treatment may modulate alter-
ations in cross-bridge mechanisms of contraction is
unknown. Therefore, the purpose of this study was to
examine the effects of IWB on peak force production
and ]7o of permeabilized single type I soleus fibers after
a 14-day period of NWB.
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METHODS
Animals. Male Sprague-Dawley rats were assigned to the
following treatment groups: caged WB (WB group), 14 days of
hindlimb NWB (NWB group), and 14 days of hindlimb NWB
with IWB treatments (IWB group). All groups were main-
tained on a 12:12-h light-dark cycle, but the WB rats were
housed separately from the NWB and IWB animals to
minimize spontaneous activity (7). All rats had ad libitum
access to chow and tap water.
Experimental treatments. NWB and IWB rats were sus-
pended from a tail harness, as previously described in detail
(7). Briefly, vinyl cloth was glued to the proximal two-thirds of
the tail, and the cloth and tail were wrapped together with
elastic tape. After the glue dried, the rats were suspended
above a horizontal grid floor by means of a fishing swivel that
passed through the apex of a small triangular wire loop
extending from the center portion of the vinyl cloth. The
height of the fishing swivel was adjusted so that the hind-
limbs of the rats were unable to contact the grid floor or any
other supportive surface. Rats were able to use their fore-
limbs to gain access to food and water. The color of the
exposed distal portion of the tail was closely monitored during
suspension to ensure that the tail harness did not obstruct
blood flow.
At 0, 4, 8, and 11.75 h of the light cycle, the IWB rats were
removed from suspension and placed in a standing position
on the grid floor. A small wire enclosure was placed over the
rats to prevent extensive walking activity. IWB rats were
resuspended after 10 min of weight support.
Single-fiber preparation. Animals were anesthetized with
pentobarbital sodium (50 mg/kg body wt ip), and one soleus
was removed, trimmed of excess fat and connective tissue,
weighed, and placed in cold relaxing solution (for composi-
tion, see below). Small bundles 1- to 2-mm wide were formed
from the muscle, pinned out at approximately in situ length,
tied to small pieces of glass capillary tubes, and stored in
skinning solution at -20°C for up to 4 wk. The skinning
solution contained (in mM) 125 K-propionate, 20.0 imidazole
(pH 7.0), 2.0 ethylene glycol-bis(_-aminoethyl ether)-N,N,N',
N'-tetraacetic acid (EGTA), 4.0 ATP, 1.0 MgC12, and 50%
glycerol (vol/vol).
On the day of an experiment, a muscle bundle was placed
in cold relaxing solution, and a single-fiber segment was
isolated and transferred into a temperature-regulated experi-
mental chamber. While under relaxing solution, the fiber
ends were attached to small stainless steel troughs by using
monofilament posts and 10-0 suture, as previously described
in detail (25). One trough was connected to a force transducer
(Cambridge model 400; Cambridge Technology, Watertown,
MA) and the other to a servo-controlled position motor
(Cambridge model 300B; Cambridge Technology). The experi-
mental chamber was mounted on an inverted microscope
stage and arranged so that it was possible to rapidly transfer
the mounted fiber into an adjacent chamber containing
activating solution (for composition, see below). Sarcomere
spacing and uniformity could be monitored in both relaxing
and activating solutions by viewing the fiber at )<800 through
the glass bottoms of each chamber. Once mounted, the fiber
was briefly bathed in relaxing solution containing 0.5%
polyoxyethylene 20 cetyl ether (Brij 58; Sigma Chemical, St.
Louis, MO) to improve sarcomere resolution and ensure
disruption of the sarcoplasmic reticulum.
Sarcomere spacing was adjusted to 2.5 tun. Fiber length
(FL) was measured as the length of the fiber segment
suspended between the two troughs and averaged 2.09 +- 0.02
(SE) mm for the 173 fibers examined in this study. A Polaroid
photo was taken of the fiber while it was briefly suspended in
air. Fiber width was determined as the mean of three
measurements made at equal intervals along the length of
the photo. Because the fiber rounds up when removed from
solution, fiber CSA was calculated by equating the mean fiber
width to fiber diameter, with the assumption of a circular
CSA.
The composition of the relaxing and activating solutions
was calculated by using the computer program of Fabiato and
Fabiato (6) and the apparent stability constants reported by
Godt and Lindley (10). The relaxing solution had a free Ca 2÷
concentration ([Ca2+]) of pCa 9.0 (where pCa = -log[Ca2+])
and contained (in mM) 20.0 imidazole, 7.0 EGTA, 10.0
caffeine, 4.74 ATP, 14.5 creatine phosphate, 5.40 MgC12, and
0.016 CaC12.2H20. The maximal activating solution, pCa 4.5,
contained (in mM) 20.0 imidazole, 7.0 EGTA, 10.0 caffeine,
4.81 ATP, 14.5 creatine phosphate, 5.26 MgC12, and 7.0
CaCI2.2H20. Both solutions contained sufficient KOH and
KC1 to achieve a pH of 7.0 and a total ionic strength of 180
mmol/l.
The temperature of the activating solution was maintained
at 15°C during all experiments. Unamplified outputs from
the force transducer and position motor were monitored on a
digital oscilloscope, amplified, and interfaced to an IBM-
compatible PC via a Lab Master DMA input-output board
(Scientific Solutions, Solon, OH). Custom-designed software
coordinated data collection, stored force and position data to
disk, and performed the calculations described below.
Peak force measurements. Peak force (in raN) was calcu-
lated as the difference between force recorded while the fiber
was in relaxing solution and the peak force obtained during
Ca 2+ activation. Po (in kN/m 2) was defined as peak force
divided by the CSA of the fiber.
Fiber E_, Peak Eo was determined from analysis of force
and position transients obtained during rapid fiber oscilla-
tion, as previously described by McDonald and Fitts (23).
While in relaxing solution, the fiber was briefly oscillated by
driving the position motor with a 1.5-kHz sine wave at an
amplitude that elicited a 0.05% peak-to-peak change in FL.
Once the fiber had attained peak isometric force, an identical
sine wave was applied to the position motor. Force and
position transients obtained in relaxing and activation solu-
tions were directed to a peak-to-peak detector circuit, where
they were converted into direct current voltage outputs
(hforce and Alength). To account for systematic contributions
to stiffness measurements, adjusted Aforce and Alength
values were obtained by subtracting Aforce and Alength
measured in relaxing solution from the values obtained
during maximal Ca 2+ activation. Eo (in kN/m 2) was calcu-
lated as (adjusted Aforce/adjusted hlength) × (FL/fiber CSA).
Fiber 11o.Vo was determined from slack-test measurements
(8, 22). Briefly, the fiber was activated at pCa 4.5 and allowed
to attain peak force. The fiber was then subjected to a rapid
(<2 ms) length step so that the fiber became slack and force
fell to zero. Force remained at zero while the fiber shortened
under no load. Once the fiber had shortened to the point
where it was no longer slack, there was a rapid redevelop-
ment of force. The fiber was then transferred back to relaxing
solution and reextended to its original FL. The entire process
was repeated at a minimum of five different slack lengths
that never exceeded 20% of FL. The times to redevelop force
were determined from each record and plotted against the
corresponding length steps (Fig. 1). The slope of the best fit
line was Vo. Vo was expressed in FL per second by normalizing
shortening velocity to FL at a sarcomere spacing of 2.5 tun.
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Fig. 1. Determination of maximal shortening velocity (Vo). A: super-
imposed position records after 5 slack steps ranging from 200 to 400
pm. B and C: corresponding superimposed force records for weight-
bearing (WB) and non-weight-bearing (NWB) type I soleus fibers,
respectively. Note similar time scales. D: time required for redevelop-
ment of force plotted against corresponding slack step. Slope of best
fit lines represents Vo (R 2 -> 0.99 for each fiber). When normalized for
fiber length (FL), Vo values for WB and NWB fibers in this example
were 1.13 and 1.67 FL/s, respectively.
MHC determination. AfLer contractile measurements were
made, the fiber was removed from the experimental appara-
tus, solubihzed in 10 pl of 1% sodium dodecyl sulfate sample
buffer (containing 6 mg/ml EDTA, 0.06 M tris(hydroxy-
methyl) aminomethane, 1% sodium dodecyl sulfate, 2 mg/ml
bromophenol blue, 15% glycerol, and 5% _-mercaptoethanol),
and stored at -80°C. Later, 0.5 nl of fiber volume was loaded
onto a Hoefer SE 600 gel electrophoresis system, consisting of
a 3% (wt/vol) acrylamide stacking gel and a 5% (wt/vol)
separating gel, and run at 4°C for 22 h. Gels were silver
stained according to the procedures described by Giulian et
al. (9). A representative gel illustrating MHC identification is
presented in Fig. 2. The fibers described in this study
contained only the slow type I MHC because these fibers
comprise the majority of soleus fibers under both WB and
NWB conditions (8, 22, 27).
Statistical analysis. Data are presented as means _+ SE.
Mean values for the WB, NWB, and IWB groups were
compared with an analysis of variance. When a significant F
ratio was obtained, the Student-Newman-Keuls post hoc
procedure was used to locate significant differences among
groups. Statistical significance was accepted at P < 0.05.
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Fig. 2. Representative 5% polyacrylamide gel illustrating myosin
heavy chain composition of soleus fibers. Lanes 1-3 represent myosin
standards prepared from rat soleus (type I), red gastrocnemius (type
IIa), and white gastrocnemius (type IIb) muscles, respectively. Lanes
4-10 represent single soleus fibers obtained from intermittent weight-
bearing (IWB) treatment group. All fibers run on this gel expressed
type I myosin heavy chain except for fiber in lane 8. Vo values for
fibers in lanes 4-10 were 1.80, 1.53, 1.59, 1.13, 3.53, 1.68, and 1.17
FL/s, respectively.
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Effect ofNWB. NWB resulted in a significant loss in
soleus muscle mass (Table 1). Compared with the W-B
controls, NWB rats displayed reductions of 40 and 45%
in absolute and relative (muscle mass/body mass) so-
leus muscle mass, respectively. Consistent with this
gross muscle atrophy was a 28% reduction in the
diameter of the type I fibers comprising the soleus
(Table 2). Fiber force production was significantly re-
duced as a result of fiber atrophy, as indicated by a 55%
drop in peak force (Table 2). However, Po also fell 16%
after NWB, indicating that atrophied fibers had a
reduced ability to produce force per unit CSA. The
histogram in Fig. 3 indicates that the majority of the
NWB fibers (27 out of 32) displayed Po values that were
less than the mean Po observed for the WB fibers. Eo
was reduced by 41% after NWB, whereas the Po/Eo
ratio increased by 40% (Table 3).
The Vo of the WB fibers expressing type I MHC was
1.17 _+ 0.04 FL/s (Table 4) and ranged from 0.66 to 2.08
FL/s. The average Vo of the NWB type I fibers was 33%
higher than the WB mean (Table 4). This increase
appeared to be the result of a rightward shift in the Vo
distribution of the NWB fibers (Fig. 4). For instance,
after NWB, 25% of the type I fibers displayed a Vo --
1.80 FL/s, whereas no fibers were observed with a Vo <
1.00 FL/s. This is in contrast to the WB type I Vo
distribution where only 3% of the fibers had a Vo -> 1.80
FL/s and 29% of the fibers had a Vo < 1.00 FL/s.
Effect of IWB. The daily IWB treatments represented
<3% of the total time spent NWB. This intervention
was effective in preventing 22% of the NWB-induced
loss in relative soleus wet weight (Table 1) and 36% of
the decline in type I fiber diameter (Table 2).
IWB was partially effective in restoring force produc-
tion of type I fibers. Although IWB fibers produced 35%
more peak force than NrWB fibers, this was still 39%
less than the force produced by the WB fibers (Table 2).
Furthermore, rWB was ineffective in attenuating the
decline in Po that occurred during 14 days of NWB
(Table 2, Fig. 3). Consistent with this observation was
the finding that the Eo of the IWB fibers remained
depressed compared with WB levels and was not statis-
tically different from the NWB value (Table 3). The
IWB Po/E o was elevated above the WB value and was
similar to the value observed for the NWB fibers.
IWB modulated the increase in type I fiber Vo that
occurred during NWB. The Vo of the type I IWB fibers
was significantly slower than that of the NVVB group
Table 1. Body and soleus weights
Body Soleus SoleusJBody
Group n Wt, g Wt, mg Wt, mg/g
WB 7 353 -+ 6 179 _- 7 0.51 -+ 0.01
N'WB 7 383-+12 107-+7" 0.28---0.01"
IWB 7 355 + 12 115 -+ 5* 0.33 -+ 0.01"¢
Values are means -+ SE of wet wt; n, no. of fibers. WB, normal
weight bearing; NW'B, hindlimb non-weight bearing; IWB, hindlimb
NW'B with intermittent weight-bearing treatments. *P < 0.05 vs.
WB. #P < 0.05 vs. NWB.
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Table 2. Diameter, peak force, and peak tension
of type I fibers
Peak
Diameter, Peak Force, Tension,
Group n }Jm mN kN/m 2
WB 66 71 -+ 1 0.51 - 0.01 130 -+ 3
NWB 32 51 -+ 2* 0.23 +-0.02* 109 - 4*
IWB 40 58 -+ l*t 0.31 -+0.01*t 117 - 3*
Values are means _+SE. *P < 0.05 vs. WB; tP < 0.05 vs. NWB.
but remained elevated above the WB mean (Table 4).
Figure 4 illustrates that the IWB Vo distribution lacked
fibers expressing a relatively high Vo because only 5% of
the fibers from this group displayed Vo values that were
>-1.80. However, the IWB mean was still elevated
compared with the WB value because only 5% of the
IWB fibers had Vo < 1.00 FL/s.
DISCUSSION
IWB and soleus atrophy. With the removal of normal
WB activity, there is a rapid and progressive loss of
soleus mass, approaching 20% after the initial 3 days of
NWB (16) and exceeding 50% of WB control values
after 28 days of NWB (29, 31). The 45% reduction in
soleus relative wet weight and the 28% decline in type I
fiber diameter noted in the present study are typical
responses to 14 days of NWB (7, 8, 22, 28). It is
currently thought that this loss of muscle mass is
primarily the result of a reduction in the tonic WB
contractile activity normally performed by the soleus in
a 1-G environment (7, 26, 28, 31). The reduced working
length of the soleus, resulting from chronic plantar
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Fig. 3. Frequency distributions of peak tension (Po) for WB (A), NWB
(B), and IWB (C) type I fibers.
Table 3. Peak elastic modulus of type I fibers
Eo,
Group n X 10 4 kN/m 2 Po/Eo
WB 25 2.09 -+ 0.09 60 +_2
NWB 12 1.24 - 0.08* 84 - 4*
IWB 23 1.44 -+ 0.05* 76 +- 3*
Values are means - SE. Eo, peak elastic modulus; Po, peak
isometric tension. *P < 0.05 vs. WB.
flexion during NWB, may contribute to the atrophic
response (28). It is not surprising that IWB would be an
effective countermeasure to NWB soleus atrophy be-
cause it most likely reverses these conditions. However,
what is noteworthy is the relatively brief amount of WB
activity required to attenuate, or even to prevent,
soleus atrophy during short-term periods of NWB. A
total of 40-60 min of normal WB activity per day, or
3-4% of the total NWB time, is sufficient to maintain
soleus mass at WB control levels during a 7-day period
ofhindlimb suspension (3, 13, 26).
In contrast, the IWB treatments in the present study
attenuated only a relatively small portion (22%) of the
soleus atrophy that occurred during NWB. The most
likely explanation for this difference is that intermit-
tent weight support is considerably less effective in
preserving soleus muscle mass over the 14 days of
NWB examined in the present study, compared with
the 7-day periods of NWB investigated by others. This
reduced effectiveness may be related to changes in the
rates of myofibril protein synthesis and degradation
that occur during hindlimb suspension. The soleus
myofibril protein synthesis rate declines to a new
steady-state level within the first few days of hindlimb
suspension, but myofibril protein degradation does not
reach its maximum rate until days 9-15 (30). Conse-
quently, the net fractional rate of soleus myofibril
protein loss peaks on day 15 of NWB (30). It seems
likely that the stimulus provided by IWB is sufficient to
preserve soleus mass during the first week of hindlimb
suspension but is less effective in preventing soleus
atrophy as the rate of protein loss rises during the
second week of NWB. This interpretation is also consis-
tent with the observation that daily 2- to 4-h periods of
WB during 28 days of hindlimb suspension attenuate
soleus atrophy to a greater degree (50%) than observed
in the present study because a new steady state of
myofibril protein metabolism has been established in
the NWB soleus by that time (30, 31).
1WB and fiber force. Both spaceflight and hindlimb
suspension are known to reduce the ability of the
rodent soleus to produce force (1, 5, 7, 29, 33). Studies
Table 4. Maximal shortening velocity of type I fibers
Group n Vo, FL/s 1
WB 66 1.17 - 0.04
NWB 32 1.56 - 0.06*
IWB 40 1.37 -+ 0.05*t
Values are means + SE. Vo, maximal shortening velocity; FL, fiber
length. *P < 0.05 vs. WB; tP < 0.05 vs. NWB.
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Fig. 4. Frequency distributions of maximal Vo for WB (A), NWB (B),
and IWB (C).
performed on single soleus fibers indicate that the
reduction in soleus force production during NWB is due
not only to gross fiber atrophy but also to a reduction in
Po, or the force produced per CSA of fiber (8, 21, 22, 27).
The recent observation that fiber Eo is also reduced
after 7-21 days of NWB suggests that the NWB-
induced reduction in Po is due to a decline in the
number of cross bridges per fiber CSA (23). This finding
is consistent with the disproportionate loss of myofibril
protein compared with the overall loss of muscle mass
that occurs during hindlimb suspension (32).
The 55% decline in force, 16% decline in Po, and 41%
reduction in Eo observed for the NWB fibers in the
present study confirm these previous conclusions. More
importantly, the present data indicate that a modest
intervention of 40 min/day of standing WB has differen-
tial effects on the two mechanisms responsible for the
loss of force during NWB. For instance, IWB increased
type I fiber peak isometric force by 35% over the NWB
condition. This partial restoration of force production
was primarily due to a reduction in the degree of fiber
atrophy experienced by the IWB fibers. In contrast, Po
and Eo were not statistically different from the NWB
condition, indicating that the IWB treatments had no
affect on NWB-induced alterations in the force pro-
duced per fiber CSA or on the number of cross bridges
per fiber CSA, respectively. Therefore, fibers from both
the NWB and IWB groups lost cross bridges at a rate
that was disproportionate to their degree of fiber atro-
phy, even though the IWB treatment effectively slowed
the rate of fiber atrophy and thereby partially restored
force production. These data further suggest that the
mechanisms responsible for the loss of force during
NWB have different degrees of responsiveness to coun-
termeasure intervention because a stimulus that effec-
tively reduced the degree of fiber atrophy had no effect
on a decline in the number of cross bridges per fiber CSA.
The reduced number of cross-bridge attachments per
CSA after IWB is likely to have important functional
consequences. At the whole muscle level, one would
expect to observe a reduction in the force produced per
CSA or per unit mass of the soleus after this treatment.
However, it has been reported that IWB maintained
soleus peak isometric force per unit mass during 7 days
of hindlimb suspension (26). The discrepancy between
these findings and the present results could be due to
the different durations of NWB as noted above.
The increase in Po/Eo after NWB is consistent with
previous results from this laboratory (23). McDonald
and Fitts (23) point out that an increase in this ratio
after NWB could represent either an increase in the
average force per cross-bridge attachment, a decrease
in fiber stiffness, or a disproportionate change in these
variables. These authors hypothesized that the in-
creased Po/Eo after NWB resulted from the loss of
contractile protein that, in turn, increased the filament
lattice spacing of the atrophied fibers. An increase in
lattice spacing has been shown to decrease both fiber
force and stiffness, with the effect on stiffness quantita-
tively greater (12). Consequently, the Po/E o would in-
crease. If this hypothesis is correct, the NWB-induced
decline in Po would result from fewer cross bridges per
fiber CSA and to a reduced force per cross bridge.
Interestingly, an increase in the spacing between thin
and thick myofilaments also results in an increase in
fiber Vo and myosin adenosinetriphosphatase activity
(19, 24), a rightward shift of the force-pCa relationship
(11), and a reduction in force per fiber CSA (11, 24), all
of which have been observed in skinned type I fibers
after NWB (8, 21, 22, 27).
The increase in Po/Eo after NWB was not prevented
by the IWB treatments in this study. The simplest
interpretation of this data is that the IWB treatments
had no effect on those factors leading to an increased
Po/Eo in the NWB condition that, on the basis of the
interpretation by McDonald and Fitts (23), would sug-
gest that the IWB treatments had no effect on proposed
filament lattice-spacing changes that may occur during
NWB. An alternative interpretation is that NWB and/or
IWB resulted in an increase in the apparent average
force per actomyosin cross bridge. This interpretation
seems less likely because the increase in force per
cross-bridge attachment would have to approach 40%.
IWB and fiber Vo. We observed a 33% increase in the
Vo of single fibers expressing type I MHC after 14 days
of NWB, a change that is in good agreement with
previous observations (8, 21, 22, 27). Although the
mechanism responsible has not been identified, the
elevated Vo does not appear to be due to undetected
levels of fast MHC in single fibers classified as type I or
to changes in myosin light-chain stoichiometry (21, 22).
In the present study, IWB reduced, but did not com-
pletely prevent, this NWB-induced increase in type I
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Vo. Interestingly, this finding appears to be the result of
a reduction in the number of fibers expressing a
relatively high Vo (i.e., Vo > 1.80 FL/s) coupled with
little restoration in the number of fibers expressing
relatively low Vo (i.e., Vo < 1.00 FL/s). Because almost
30% of the type I WB population expressed Vo val-
ues < 1.00 FL/s, the overall mean Vo of the IWB group
remained elevated compared with the WB condition. It
is known that soleus muscle activity shifts from a tonic
to a phasic pattern during hindlimb suspension (28). If
that same pattern is maintained during the periods of
IWB, those fibers with a relatively high Vo may be
recruited to a greater extent during standing and may
thereby display a greater adaptation to the IWB treat-
ment. However, this mechanism remains speculative
because it is impossible to determine from the present
data whether the reduced number of high Vo fibers
represent a reduction in Vo of a specific population of
fibers, with little change in the remaining nonrespon-
sive fibers, or whether all fibers in the IWB fiber
population simply shifted toward lower velocities.
Summary and recommendations. To summarize, IWB
treatments that totaled <3% of the entire time spent
NWB appear to be considerably less effective in prevent-
ing soleus muscle atrophy over a period of 14 days than
previously observed for shorter periods of NWB. Never-
theless, this treatment reduced soleus muscle atrophy
and attenuated (but did not prevent) alterations in
soleus type I fiber diameter, peak force production, and
Vo. In contrast, IWB had little effect on NWB-induced
reductions in type I fiber Po and Eo, which suggests that
reductions in actomyosin cross-bridge attachments per
fiber CSA are more resistant to countermeasure inter-
vention.
The inability of the IWB treatment to prevent changes
in single-fiber contractile function over 14 days of NWB
is a shortcoming of this countermeasure. It remains to
be determined whether normal fiber function could be
maintained with a modified IWB protocol that incorpo-
rates changes in the duration and/or the number of
daily WB sessions. Previous work suggests that it is the
number of sessions each day, rather than the duration
of each session, that is the primary factor in determin-
ing the effectiveness of IWB as a countermeasure (3).
An alternative to IWB would be to incorporate more
forceful muscle contractions into the countermeasure
treatment because recent studies have demonstrated
the effectiveness of high-intensity resistance exercise
in maintaining soleus mass and muscle tension during
7-10 days of NWB (14, 18).
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